These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 6441856)

  • 1. [15 years of Rh-immunization prevention program].
    Eklund J; Nevanlinna HR
    Katilolehti; 1984; 89(8):284-7. PubMed ID: 6441856
    [No Abstract]   [Full Text] [Related]  

  • 2. [Current viewpoints in the anti-D prevention of rhesus alloimmunization in the pregnant woman and of hemolytic disease of the newborn infant (a review of the literature)].
    Spasova K; Vŭlcheva B
    Akush Ginekol (Sofiia); 1986; 25(3):84-90. PubMed ID: 3019168
    [No Abstract]   [Full Text] [Related]  

  • 3. Rhesus immunization: new perspectives in maternal-fetal medicine.
    Stangenberg M; Selbing A; Lingman G; Westgren M
    Obstet Gynecol Surv; 1991 Apr; 46(4):189-95. PubMed ID: 1902926
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prevention with anti-D gamma globulin at the Research Institute of Obstetrics and Gynecology].
    Spasova K; Vŭlcheva B
    Akush Ginekol (Sofiia); 1984; 23(6):500-4. PubMed ID: 6099699
    [No Abstract]   [Full Text] [Related]  

  • 5. Economics of anti-rhesus prophylaxis in an African population.
    Verkuyl DA
    Cent Afr J Med; 1987 Feb; 33(2):32-7. PubMed ID: 3121186
    [No Abstract]   [Full Text] [Related]  

  • 6. [Errors in the prevention of Rh incompatibility].
    Dmoch E
    Acta Haematol Pol; 1988; 19(1-2):59-61. PubMed ID: 3149111
    [No Abstract]   [Full Text] [Related]  

  • 7. [Prevention of fetomaternal anti-rhesus-D allo-immunization: methods used and topics discussed].
    Carbonne B; Goffinet F; Marpeau L
    J Gynecol Obstet Biol Reprod (Paris); 2006 Feb; 35(1 Suppl):1S85-1S86. PubMed ID: 16495832
    [No Abstract]   [Full Text] [Related]  

  • 8. [Comparative analysis of the effects to date of the prevention of Rh incompatibility].
    Jedwabny A; Suchocki S; Bobrowska G
    Acta Haematol Pol; 1988; 19(1-2):56-8. PubMed ID: 2853507
    [No Abstract]   [Full Text] [Related]  

  • 9. [Studies on manifestations of Rh-related hemolytic disease of the newborn in the years 1974-1989 in the Erfurt district].
    Töpke B; Menzel K; Uhlig R; Pfister U
    Kinderarztl Prax; 1991 Apr; 59(4):111-6. PubMed ID: 1905365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pregnancy and immunization].
    Tamsen L; Lindberg B
    Jordemodern; 1990; 103(1-2):14-20. PubMed ID: 2108941
    [No Abstract]   [Full Text] [Related]  

  • 11. [Novel treatments of Rh-immunization].
    Ulander VM; Halmesmäki E; Ammälä P
    Duodecim; 2004; 120(24):2897-904. PubMed ID: 15700584
    [No Abstract]   [Full Text] [Related]  

  • 12. [Immunologic conflict due to erythrocytic antigens (its prevention and treatment)].
    Shalimova MA
    Feldsher Akush; 1988 Dec; 53(12):26-30. PubMed ID: 3148481
    [No Abstract]   [Full Text] [Related]  

  • 13. [Prenatal immunoglobulin prevention in Rh(D)-negative nonsensitized pregnant women].
    Katsulov A
    Akush Ginekol (Sofiia); 1997; 36(2):1-2. PubMed ID: 9471891
    [No Abstract]   [Full Text] [Related]  

  • 14. Preventing RhD haemolytic disease of the newborn. Services should be centralised for pregnancies affected by RhD haemolytic disease.
    Craig JS; McClure BG; Tubman TR
    BMJ; 1998 May; 316(7144):1611. PubMed ID: 9616034
    [No Abstract]   [Full Text] [Related]  

  • 15. [The prevention of Rh immunization].
    Nevanlinna HR
    Duodecim; 1968; 84(23):1330-2. PubMed ID: 4973721
    [No Abstract]   [Full Text] [Related]  

  • 16. The experience and effectiveness of the Nova Scotia Rh program, 1964-84.
    Baskett TF; Parsons ML; Peddle LJ
    CMAJ; 1986 Jun; 134(11):1259-61. PubMed ID: 3011235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Response to the comment by N. Lahmann on "Current problems of blood group incompatibility in pregnancy"].
    Wilken H
    Zentralbl Gynakol; 1989; 111(6):388-9. PubMed ID: 2499138
    [No Abstract]   [Full Text] [Related]  

  • 18. [Feto-maternal blood immunization. Screening, prevention].
    Poissonnier MH; Tournaire M
    Rev Prat; 1992 Dec; 42(20):2643-6. PubMed ID: 1299956
    [No Abstract]   [Full Text] [Related]  

  • 19. [Prevention of hemolytic disease of the fetus and the newborn: it is necessary to act].
    Mannessier L; Alie-Daram S; Roubinet F; Valat AS; Depoortère MH; Fournié A; Puech F
    J Gynecol Obstet Biol Reprod (Paris); 2000 Sep; 29(5):441-4. PubMed ID: 11011272
    [No Abstract]   [Full Text] [Related]  

  • 20. On the immunologic basis of Rh immune globulin (anti-D) prophylaxis.
    Kumpel BM
    Transfusion; 2006 Sep; 46(9):1652-6. PubMed ID: 16965599
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.